Specialty
Aesthetics Cataract & Refractive Dermatology General Ophthalmology Glaucoma Interventional Radiology Neurology Optometry Retina Women's Health View All Courses
Course Type
Supplement Multimedia Webinar In-Person Multi-Part Collection
Search
Log In

Advanced Refractive Congress (Day 2)

This course has expired. You can still review the content but course credit is no longer available.

In Person Credits: 5

Expiration Date: Wednesday, January 31, 2018
Release Date: July 30, 2017

Accreditation and Designation Statement

Accreditation Statement

This course is COPE approved for 5.0 hour of CE credit(s) for optometrists

COPE Course ID: 54537-RS

COPE Activity ID: 113940

 

Administrator

Evolve Medical Education LLC

 

This course has been approved by the Florida Board of Optometry

Faculty and Disclosures

Mohamed Abou Shousha, MD has had no financial agreements or affiliations during the past year.

Zaina Al-Mohtaseb, MD has had no financial agreements or affiliations during the past year.

Quentin Allen, MD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau: Alcon and Bausch + Lomb.

Carlos Arce, MD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau: Ziemer Ophthalmics.
Shamik Bafna, MD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau: AcuFocus, Inc. and Carl Zeiss Meditec.
Sondra Black, OD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau: AcuFocus, Inc.; Johnson & Johnson; and Lacrivera; and Valeant Pharmaceuticals, Inc.

Eric Brooker, OD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau: AcuFocus, Inc.; BioD; Lacrivera; and Visionmetrics.

Carlos Buznego, MD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau:  Allergan; Bausch + Lomb; Glaukos Corporation; and Sun Pharmaceutical. Grant/Research Support: Glaukos Corporation. Stock/Shareholder: Glaukos Corporation.
Kendall Donaldson, MD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau:  Abbott Medical Optics; Alcon; Allergan Plc; Biotissue; Bausch + Lomb ; Johnson & Johnson; NovaBay; Omeros Corporation; Shire Plc; Sun Pharmaceuticals; and TearLab.
John Doane, MD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau: Carl Zeiss Meditec and Rx Sight. Grant/Research Support: Carl Zeiss Meditec and Rx Sight. Stock/Shareholder: Presbyopia Therapies.

Alice Epitropoulos, MD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau:  Alcon; Allergan Plc; Abbott Medical Optics; Bausch + Lomb; BioTissue; Omeros Corporation; NovaBay, PRN Physician Recommended Nutraceuticals; RPS; Shire Plc; Sun Pharmaceuticals, TearLab Corporation, TearScience. Other Financial Support: EpiGlare Tester.

Lance Forstot, MD has had no financial agreements or affiliations during the past year.

John Gelles, OD, FIAO, FCLSA has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau:  Avedro; BioTissue; Blanchard Lab; Bausch + Lomb; Contamac; EyecareLive; Formulens; and Visionary Optics.  Stock/Shareholder: Cool Doctors, Inc.

Arun Gulani, MD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau:  Avedro; BioTissue; Blanchard Lab; Bausch + Lomb; Contamac; EyecareLive; Formulens; Google; and Visionary Optics.

Ranya Habash, MD has had no financial agreements or affiliations during the past year.

Kathryn Hatch, MD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau:  Allergan Plc; Alimera Sciences; Omeros Corporation; and Shire Plc.

Jessica Heckman, OD has had no financial agreements or affiliations during the past year.

Simon Holland, MD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau:   Alcon; Allergan Plc; and SCHWIND. Grant/Research Support: Alcon.

Guy Kezirian, MD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau:  Refractive Surgery Alliances, Inc.; and SurgiVision Consultants, Inc.

Sumitra Khandelwal, MD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau:  Allergan Plc; Omeros Corporation; and Shire Plc.

  1. Brian Kim, MD has had no financial agreements or affiliations during the past year.

Steven Klyce, PhD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau: NIDEK; NTK Enterprises; and Oculus.

Mark Kontos, MD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau: Allergan Plc; Johnson & Johnson; and Shire Pharmaceuticals.

Ronald Krueger, MD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau: Alcon. Stock/Shareholder: Calhoun Vision and Presbia.

Nicole Lemanski, MD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Grant/Research Support: Nidek.

Jennifer Loh, MD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau: Allergan Plc; Johnson & Johnson; and Shire Plc; and Sun Pharmaceuticals.

Jodi Luchs, MD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau: Allergan Plc; Bausch + Lomb; Omeros; Shire Plc; Sun Pharmaceuticals; and Tear Lab. Grant/Research Support: Alcon; Allergan Plc; Auven; Bausch + Lomb; Kala, Icare; Refocus; and Shire Plc. Stock/Shareholder: Calhoun Vision; CXLO, Insightful Solutions; Omega Ophthalmics; RPS; and Trefoil Therapeutics.

Grace Lytle, OD, MS has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau: Avellino Labs. Other Financial Support: Avedro, Inc.

Ahad Mahootchi, MD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau: Imprimis; Irident; and Valeant Pharmaceuticals.

Parag Majmudar, MD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau:  Alcon; Allergan Plc; Shire Plc; and Sun Pharmaceuticals. Stock/Shareholder: CXL Ophthalmics and RPS.

Marguerite McDonald, MD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau:  Alcon; Allergan Plc; Abbott Medical Optics; Bausch + Lomb; Focus Labs; Ocusoft, Omeros Corporation; ORCA Surgical; Shire Plc; TearLabs; and TearScience.

Andrew Morgenstern, MD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau:  Alcon; Allergan Plc; Brauder Ophthalmic; Oculus; OcuSoft; and Sun Pharmaceuticals.

Anita Nevyas-Wallace, MD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau:  PRN Physician Recommended Nutraceuticals and Mastel. Stock/Shareholder: Arcscan and Varitronics Inc.

Jay Pepose, MD had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau:  AcuFocus, Bausch + Lomb; Johnson & Johnson; and TearLab. Stock/Shareholder: AcuFocus and Mimetogan.

Laura Periman, MD had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau:  Allegan Plc; Bausch + Lomb; BioTissue; Lumenis, ScienceBasedHealth; TearLab, and Topcon.

Karolinne Rocha, MD has had no financial agreements or affiliations during the past year.

Clifford Salinger, MD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau:  Avellino Labs; Bausch + Lomb; BioTissue; Shire Plc; and Tear Lab.

Marcony Santhiago, MD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau:  Alcon and Ziemer Ophthalmic Systems.

Julie Schallhorn, MD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau:  Avellino Labs.

Barry Schecter, MD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau:  Shire Plc; Sun Pharmaceuticals; and Valeant Pharmaceuticals. Grant/Research Support: Johnson & Johnson.

Nathan Schramm, OD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau:  Bausch + Lomb; Fortifye Vitamins; and Scleral Lens Education Society. Grant/Research Support: Contact Lens Assessment in Youth (CLAY) Study.

Christine Sindt, OD Christine Sindt, OD, FAAO, FSLS has had no financial agreements or affiliations during the past year. has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau:  Alcon, Allergan Plc, NovaBay; and Valeant Pharmaceuticals.

Priyanka Sood, MD has had no financial agreements or affiliations during the past year

William Trattler, MD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau:  Allergan Plc; Abbott Medical Optics; Alcon Bausch + Lomb; NovaBay; Shire Plc; and Sun Pharmaceuticals. Stock/Shareholder: CXLO.

Bennett Walton, MD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau: Alcon.

Ming Wang, MD, PhD has had no financial agreements or affiliations during the past year.

Walter Whitley, MD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau:  Alcon; Allergan Plc; Bausch + Lomb; Biotissue; Glaukos Corporation; Johnson & Johnson;  Ocusoft; Omeros Corporation; TearScience; TearLab; ScienceBased Health; and Sun Pharmaceuticals.

Helen Wu, MD has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau:  Allergan Plc; Omeros Corporation; and Shire Plc.

Bavand Youssefzadeh, MD has had no financial agreements or affiliations during the past year.

Richard Yee, MD has had no financial agreements or affiliations during the past year.

 

 

If you have participated in the live educational activity “Advanced Refractive Congress (Day 2)”, please continue to the course evaluation to receive your certificate.

BackNext